November
Drug Discovery Biology
Strategy Meeting East Coast USA 2024
Assessing, Choosing And Optimizing The Right Set Of Data And Methodologies To Help With Finding Effective Modalities And Techniques For Drug Discovery Biology
What makes our strategy meetings unique?
Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our upcoming strategy meeting.
Andrea Weston
Executive Director, Cellular, Genomic, and Protein Sciences PfizerAnitha Krishnan
Executive Director, Research Aviceda TherapeuticsBertrand Le Bourdonnec
Chief Scientific Officer HDAX TherapeuticsCara Williams
Vice President Head of Preclinical Biology, Inflammation & Immunology Research Unit PfizerCarlos Pedraza
AVP Biology Sai Life SciencesChangyun Hu
Chief Scientific Officer Adept TherapeuticsDavid Winkler
Executive Director Biology IFM TherapeuticsDiane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center Boston UniversityDeepika Sharma Das
Director, Portfolio Strategy & Partnerships, Global Research & Early Development Novo NordiskDhruv Sethi
Senior Director, Discovery Obsidian TherapeuticsHongwei Han
Associate Director, Head of In Vivo Pharmacology Generate:BiomedicinesHuseyin Mehmet
Executive Director. New Ventures University of Massachusetts Medical SchoolJason Wu
Machine Learning Scientist II SanofiJonathan Castillo
Associate Director Biology & Biophysics Sai Life SciencesKevin Knockenhauer
Associate Director Accent TherapeuticsLarry R. Brown
Executive Vice President, Chief Scientific Officer Noveome Biotherapeutics, Inc.Laura Zawadzke
Executive Director of Chemical and Structural Biology LifeMine TherapeuticsMartin Marro
Executive Director, Cell Pharmacology, Obesity & Complications Eli Lilly and CompanyMohammad Shadid
Vice President, Preclinical Development Korro BioPrasoon Chaturvedi
Vice President, Head of DMPK C4 Therapeutics, Inc.Zev Wisotsky
Director, Drug Discovery New Modality Solutions Revvity SignalsSee Which Topics Are Discussed at the Strategy Meeting
An Emerging Paradigm: Cellular Therapeutics without Cells
Roundtable Tracks
1Moving from target identification to novel small molecule leads: Strategies for target validation, defining a target modulation profile, and setting up a successful hit-ID campaign
-Andrea Weston
Executive Director, Cellular, Genomic, and Protein Sciences
Pfizer
DMPK / ADME Toxicology
Assessing current advancements in PBPK absorption modeling and its challenges
-Prasoon Chaturvedi
Vice President, Head of DMPK
C4 Therapeutics, Inc.
In Vivo and In Vitro Pharmacology
Enhancing Preclinical dose projection with appropriate biomarkers to facilitate clinical development
-Cara Williams
Vice President Head of Preclinical Biology, Inflammation & Immunology Research Unit
Pfizer
Structural Biology and Biophysics
Unveiling Drug Targets: The Crucial Role of Structural Biology and Biophysics in Modern Drug Discovery
-Kevin Knockenhauer
Associate Director
Accent Therapeutics
In Silico Biology
Evaluating practical uses of latest AI/ML tools to expedite and increase efficiency in drug discovery process
-Diane Joseph-McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center
Boston University
Strategic Partnerships Investment & Collaborations
Roundtable Tracks
2Recent Headways into PROTACs, Molecular Glues, PPIs as Pharmacological Targets
-Carlos Pedraza
AVP Biology
Sai Life Sciences
Sponsor
DMPK / ADME ToxicologySponsor
In Vivo and In Vitro PharmacologyOpportunities and risks in the preclinical development of molecules that do not cross react with rodents
-Anitha Krishnan
Executive Director, Research
Aviceda Therapeutics
Sponsor
Structural Biology and BiophysicsConceptualizing Drug-Target Interactions at the Next Level: Targeted Protein Degraders
-Jonathan Castillo
Associate Director Biology & Biophysics
Sai Life Sciences
Sponsor
In Silico BiologySponsor
Strategic Partnerships Investment & CollaborationsSponsor
Roundtable Tracks
3Enumerating Criteria Selection Of Appropriate Modalities And Hit ID Strategies For First In Class Targets
-Martin Marro
Executive Director, Cell Pharmacology, Obesity & Complications
Eli Lilly and Company
DMPK / ADME Toxicology
Utility of Microphysiological Systems in the Drug Development of Oligonucleotide Therapeutics
-Mohammad Shadid
Vice President, Preclinical Development
Korro Bio
In Vivo and In Vitro Pharmacology
Structural Biology and Biophysics
Applications of Structural Biology and Biophysics in Cell and Gene Therapies
-Dhruv Sethi
Senior Director, Discovery
Obsidian Therapeutics
In Silico Biology
Harnessing The Promise Of Generative AI To Transform Drug Discovery Hence Forward
-Jason Wu
Machine Learning Scientist II
Sanofi
Strategic Partnerships Investment & Collaborations
Leveraging On Academic Partnerships To Further Drug Discovery And Development Operations
-Huseyin Mehmet
Executive Director. New Ventures
University of Massachusetts Medical School
Roundtable Tracks
4Gene Dependency Screens and Targeted Chemical Library of Screens for Identification of Targets Relevant to Phenotypic Assays
-David Winkler
Executive Director Biology
IFM Therapeutics
DMPK / ADME Toxicology
Advances in computational models and machine learning techniques for a more precise prediction of ADME properties and process
-Bertrand Le Bourdonnec
Chief Scientific Officer
HDAX Therapeutics
In Vivo and In Vitro Pharmacology
Evaluating engineered organ- on-chip technology and other multicellular technologies to interrogate complex pharmacology and build understanding of human translation (Topic TBC)
-Hongwei Han
Associate Director, Head of In Vivo Pharmacology
Generate:Biomedicines
Structural Biology and Biophysics
Biophysical Methods for Visualizing Drug-Target Interactions: Solutions for membrane targets
-Laura Zawadzke
Executive Director of Chemical and Structural Biology
LifeMine Therapeutics
In Silico Biology
Decoding Omics Data Interpretation, integration, and Application in Drug Discovery through the lense of In Silico Biology
-Changyun Hu
Chief Scientific Officer
Adept Therapeutics
Strategic Partnerships Investment & Collaborations
Assessing Financing Models: Which Path Fits Your Organization
-Deepika Sharma Das
Director, Portfolio Strategy & Partnerships, Global Research & Early Development
Novo Nordisk
Reasons To Attend Our Strategy Meetings
Fully Interactive Format
There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter
Senior Decision Makers
All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard
Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you
Private and Intimate Networking
Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution
Event Gallery
Press play to hear what your colleagues had to say…
Hotel & Venue
Le MĂ©ridien Boston Cambridge
Le Méridien Cambridge-MIT’s elegant guest rooms and suites offer a place of luxurious sanctuary and unmatched comfort. Explore unique programs inspired by the brand’s European heritage. Born in a glamorous era of travel, Le Méridien believes everyone should explore the world in style.
Hotel Details Maps & Direction ParkingHere To Help
Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.